Item 4.01. Change in Registrant's Certifying Accountant.

(a) Dismissal of Former Independent Registered Public Accounting Firm

On October 18, 2023, the Board of Directors of Medicale Corp. (the "Company") was informed that Gries & Associates, LLC ("Gries & Associates") had sold its business to GreenGrowth CPAs ("GreenGrowth") and subsequently approved the dismissal of Gries & Associates, LLC ("Gries & Associates") as the Company's independent registered public accounting firm, effective immediately.

Gries & Associates's reports on the Company's financial statements as of June 30, 2023 contained no adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except to indicate that there was substantial doubt about the Company's ability to continue as a going concern.

In connection with the audits of the Company's consolidated financial statements in the interim period through June 30, 2023, there were no disagreements with Gries & Associates on any matters of accounting principles or practices, financial statement disclosure or auditing scope and procedures which, if not resolved to the satisfaction of Gries & Associates, would have caused Gries & Associates to make reference to the matter in their report. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) in the subsequent interim period through June 30, 2023.

In accordance with Item 304(a)(3) of Regulation S-K, on October 18, 2023, the Company provided Gries & Associates with a copy of the foregoing disclosures and requested that Gries & Associates provide a letter addressed to the SEC stating whether it agrees with such disclosures. A copy of Gries & Associates's letter dated October 23, 2023 is filed as Exhibit 16.1 to this Current Report on Form 8-K.

(b) Appointment of New Independent Registered Public Accounting Firm

On October 23, 2023, the Board of Directors of the Company approved the appointment of GreenGrowth as the Company's new independent registered public accounting firm for the fiscal year ending September 30, 2023. During the Company's interim period through June 30, 2023, neither the Company nor anyone acting on its behalf consulted with Gries & Associates with respect to either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the consolidated financial statements of the Company, and no written report or oral advice was provided by Gries & Associates to the Company that Gries & Associates concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue, or (ii) any matter that was the subject of either a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).

Attachments

Disclaimer

Medicale Corporation published this content on 11 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 December 2023 12:51:21 UTC.